In contrast, however, the inhibition of DGAT1 activities in the skeletal muscle or macrophage may cause insulin resistance, leading to aggravation of metabolic disorders, as a result of inhibited conversion of fatty acids substrates which induce insulin resistance into the form of triglyceride [23], [24]. The gene discussed is INS; the disease is metabolic disease.